Live Analyst Rating Changes 23245 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Chase Knickerbocker
C-H

Chase Knickerbocker

Wall Street Analyst
★★★☆☆
#1511
on 13Foresight · ranked by our own returns
53%
Success Rate
+12.7%
Average Return
42 of 79 calls profitable · +5.9% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 53% of Chase Knickerbocker's ratings turned a profit when each position was held for 1 year — averaging +12.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

266 Buy 10 Hold 0 Sell
Chase's Stock Coverage 46 ratings · 2026-08-12
Company Date Position Consensus Price Target 1-Yr Return vs S&P 500
CVRX
CVRx
Aug 11, 2026 HOLD Buy
+190.5% avg upside
9 analysts
· ·
DCTH
Delcath Systems
Aug 07, 2026 BUY Strong Buy
+27.8% avg upside
11 analysts
$24.00
39.40% Upside
· ·
BVS
Bioventus
Aug 06, 2026 BUY Strong Buy
-2.9% avg upside
8 analysts
$18.00
29.93% Upside
-0.8% ·
KRMD
REPRO-MED Systems
Aug 06, 2026 BUY Strong Buy
+86.0% avg upside
9 analysts
$6.00
73.94% Upside
-0.3% ·
MYO
Myomo
Aug 06, 2026 BUY Strong Buy
+399.7% avg upside
9 analysts
$1.70
12.59% Upside
+8.4% ·
INDV
Indivior
Aug 04, 2026 BUY Strong Buy
-2.6% avg upside
10 analysts
$53.00
37.95% Upside
+6.1% ·
PHAT
Phathom Pharmaceuticals
Jul 31, 2026 BUY Strong Buy
+210.8% avg upside
14 analysts
$20.00
134.99% Upside
-2.1% ·
BFLY
Butterfly Network
Jul 31, 2026 BUY Strong Buy
-41.8% avg upside
8 analysts
$10.00
6.68% Upside
+36.4% ·
ETON
Eton Pharmaceuticals
Jul 28, 2026 BUY Strong Buy
-15.9% avg upside
9 analysts
$62.00
47.50% Upside
-6.4% ·
PYPD
PolyPid
Jul 22, 2026 BUY Strong Buy
+235.2% avg upside
7 analysts
$12.00
153.64% Upside
+21.0% ·
GUTS
Fractyl Health, Inc.
Jul 16, 2026 BUY Strong Buy
+557.2% avg upside
7 analysts
$4.00
469.93% Upside
-18.1% ·
CELC
Celcuity
Jul 15, 2026 BUY Strong Buy
+40.5% avg upside
16 analysts
$178.00
102.06% Upside
-0.8% ·
IRWD
Ironwood Pharma
Jul 14, 2026 BUY Buy
+178.5% avg upside
23 analysts
+8.5% ·
HROW
Harrow Health
Jul 13, 2026 BUY Strong Buy
+36.7% avg upside
12 analysts
$59.00
49.62% Upside
-4.3% ·
GRCE
Grace Therapeutics
Jul 13, 2026 BUY Strong Buy
+168.9% avg upside
9 analysts
-13.2% ·
XERS
Xeris Pharmaceuticals
Jul 08, 2026 BUY Strong Buy
+15.3% avg upside
10 analysts
$12.00
43.10% Upside
-3.1% ·
MDXG
MiMedx Group
Jul 06, 2026 BUY Strong Buy
+148.5% avg upside
17 analysts
+5.2% ·
WEST
Westrock Coffee
Jul 01, 2026 BUY Strong Buy
+20.7% avg upside
8 analysts
+9.0% ·
MAMA
Mama's Creations
Jun 30, 2026 BUY Strong Buy
+29.0% avg upside
9 analysts
-1.0% ·
DMAC
Diamedica Therapeutics
Jun 24, 2026 BUY Strong Buy
+116.7% avg upside
12 analysts
+4.8% ·
ACOG
Alpha Cognition Inc
Jun 17, 2026 BUY Strong Buy
+87.6% avg upside
4 analysts
+27.5% ·
XTNT
Xtant Medical Holdings
May 13, 2026 BUY Strong Buy
+1728.2% avg upside
9 analysts
-8.3% ·
NRXS
NeurAxis, Inc.
May 11, 2026 BUY Strong Buy
+18.1% avg upside
3 analysts
-13.0% ·
FENC
Fennec Pharmaceuticals
Apr 22, 2026 BUY Strong Buy
+27.1% avg upside
9 analysts
+63.8% ·
MDWD
Mediwound
Apr 06, 2026 BUY Strong Buy
+54.9% avg upside
13 analysts
-15.7% ·
BLBD
Blue Bird
Nov 20, 2025 BUY Strong Buy
+10.3% avg upside
11 analysts
+26.1% ·
SMTC
Semtech
Nov 19, 2025 BUY Strong Buy
+9.9% avg upside
24 analysts
+116.2% ·
MXL
Maxlinear
Oct 20, 2025 BUY Strong Buy
+5.5% avg upside
17 analysts
+292.1% ·
OKLO
Oklo Inc
Oct 17, 2025 HOLD Strong Buy
+100.5% avg upside
25 analysts
-71.6% ·
LGND
Ligand Pharma
Oct 09, 2025 BUY Strong Buy
-6.2% avg upside
15 analysts
+60.8% ·
INOD
Innodata
Oct 08, 2025 BUY Strong Buy
+96.2% avg upside
8 analysts
-33.1% ·
KORU
Direxion MSCI Daily South Korea Bull 3X Shares
Aug 07, 2025 BUY Strong Buy
1 analyst
· ·
CDLX
Cardlytics
Jul 23, 2025 HOLD Hold
+458.7% avg upside
16 analysts
· ·
AEHR
Aehr Test Systems
Jul 22, 2025 BUY Strong Buy
+0.2% avg upside
4 analysts
+365.4% ·
NEXN
Nexxen International
Jul 14, 2025 BUY Strong Buy
+10.4% avg upside
16 analysts
-0.1% ·
TRLV
Trulieve Cannabis
Feb 26, 2025 BUY Strong Buy
+141.1% avg upside
15 analysts
$11.50
23.75% Upside
+57.4% ·
RMNI
Rimini Street
Feb 05, 2025 BUY Buy
+45.6% avg upside
9 analysts
+8.1% ·
OMCL
Omnicell
Aug 28, 2024 BUY Strong Buy
+33.0% avg upside
12 analysts
-26.4% ·
ALKT
Alkami Technology
Aug 01, 2024 BUY Strong Buy
+24.1% avg upside
16 analysts
$38.00
91.70% Upside
-39.5% ·
SPIR
Spire Global
Jul 18, 2024 BUY Strong Buy
-2.7% avg upside
12 analysts
-11.0% ·
OABI
OmniAb
Mar 21, 2024 BUY Strong Buy
+127.7% avg upside
10 analysts
$10.00
195.92% Upside
-50.8% ·
CSBR
Champions Oncology
Oct 16, 2023 BUY Strong Buy
+69.7% avg upside
6 analysts
-27.7% ·
ISPC
iSpecimen
Sep 13, 2023 BUY Strong Buy
+86.4% avg upside
3 analysts
· ·
FSLY
Fastly
Aug 18, 2023 BUY Buy
+17.1% avg upside
26 analysts
-66.5% ·
INFU
InfuSystem Holdings
May 04, 2023 BUY Strong Buy
+29.6% avg upside
7 analysts
-11.3% ·
ZG
Zillow Group Class A
May 03, 2023 BUY Buy
+65.2% avg upside
46 analysts
$58.00
69.19% Upside
-3.4% ·
🔒 41 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Chase Knickerbocker — Frequently Asked Questions
How accurate are Chase Knickerbocker's stock ratings?
Based on the calls 13Foresight could measure, about 53% of Chase's ratings were profitable over a one-year hold, with an average return of +12.6% per rating, or +5.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Chase ranked on 13Foresight?
Chase Knickerbocker is currently ranked #1511 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Chase cover?
Chase most recently has ratings on CVRX, DCTH, BVS, KRMD, MYO, INDV, PHAT, BFLY, ETON, PYPD, GUTS, CELC and 34 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.